Cisplatin inhibits the proliferation of Saos-2 osteosarcoma cells via the miR-376c/TGFA pathway

  • Yuan Wang Department of Orthopedic Disease and Oncology Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China
  • Yichao Wu Department of Orthopedics, Fourth Affiliated Hospital of Anhui Medical University, Hefei, China
  • Awei Cai Department of Orthopedic Disease and Oncology Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China
  • Chengxiao Ma Department of Orthopedic Disease and Oncology Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China
  • Shang Cai Department of Orthopedic Disease and Oncology Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China
  • Hao Wang Department of Orthopedic Disease and Oncology Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China
  • Yukang Que Department of Orthopedic Disease and Oncology Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China
  • Shenglin Xu Department of Orthopedic Disease and Oncology Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China
  • Tangbing Xu Department of Orthopedics, Fourth Affiliated Hospital of Anhui Medical University, Hefei, China
  • Yong Hu Department of Orthopedic Disease and Oncology Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China https://orcid.org/0000-0003-3411-9977
Keywords: Cisplatin, miR-376c, transforming growth factor alpha, TGFA, Saos-2, cell proliferation, cell growth, osteosarcoma

Abstract

Transforming growth factor alpha (TGFA) gene is involved in the proliferation and metastasis of various tumors, but its role in cell sensitivity to cisplatin chemotherapy is unclear. In this study, we investigated the mechanism underlying inhibitory effects of cisplatin on growth and proliferation of osteosarcoma cells. Osteosarcoma and normal skeletal muscle tissues were collected from 26 patients by biopsy. TGFA was silenced or overexpressed in Saos-2 osteosarcoma cells by transfection with TGFA-shRNA or TGFA ORF clone, respectively. MiR-376c was inhibited or overexpressed by transfection of Saos-2 cells with miR-376c sponge or miR-376c mimics, respectively. Cell growth was analyzed by MTT assay and cell proliferation by BrdU assay. MiR-376c and TGFA mRNA expression was detected by quantitative reverse transcription PCR and TGFA protein expression by Western blot. The target relationship between miR-376c and TGFA was assessed by luciferase reporter assay. Both in osteosarcoma tissues and Saos-2 cells, miR-376c expression was significantly decreased and TGFA mRNA expression was significantly increased compared with control. Transfection of Saos-2 cells with TGFA-shRNA silenced TGFA expression and significantly inhibited cell growth and proliferation. TGFA mRNA and protein expression in Saos-2 cells significantly decreased with increasing cisplatin concentrations (2.5–10 mg/L). Transfection with TGFA ORF clone reversed the inhibitory effects of cisplatin on Saos-2 cell proliferation. Compared with cisplatin (10 mg/L) treatment alone, the combined treatment with cisplatin and miR-376c mimics inhibited the proliferation of Saos-2 cells more significantly. MiR-376c suppressed TGFA expression by directly interacting with its 3'-UTR region. Overall, cisplatin inhibited the proliferation of Saos-2 cells by upregulating miR-376c and downregulating TGFA expression.

Downloads

Download data is not yet available.
Cisplatin inhibits the proliferation of Saos-2 osteosarcoma cells via the miR-376c/TGFA pathway
Published
2020-02-05
How to Cite
1.
Wang Y, Wu Y, Cai A, Ma C, Cai S, Wang H, Que Y, Xu S, Xu T, Hu Y. Cisplatin inhibits the proliferation of Saos-2 osteosarcoma cells via the miR-376c/TGFA pathway. Bosn J of Basic Med Sci [Internet]. 2020Feb.5 [cited 2020Feb.23];. Available from: http://bjbms.org/ojs/index.php/bjbms/article/view/4485
Section
Pathology